Clinical Trials
56 trialsREVEAL
Ono Pharmaceutical Co., Ltd.
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
AstraZeneca
EXGEFATU
University Hospital Tuebingen
Longitudinal Studies of Patient With FPDMM
National Institutes of Health Clinical Center (CC)
BEAMER
Technical University of Madrid
IRBTR
Children's National Research Institute
EGR2
Assistance Publique - HĂ´pitaux de Paris
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
MPN Research Foundation
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
UNIQUE
University Health Network, Toronto
Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Prisma Health-Upstate
SONCO
Assistance Publique - HĂ´pitaux de Paris
Longitudinal Registry Including Patients Treated With Heavy Particles
CNAO National Center of Oncological Hadrontherapy
IRCPSS
University Hospital, Geneva
CoRDS
Sanford Health
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Associazione Angela Serra per la ricerca sul cancro
SarcBOP
University Hospital Heidelberg
PaS
Istituto Ortopedico Rizzoli
PREDICT-LRS
IRCCS Azienda Ospedaliero-Universitaria di Bologna
SIRIUS
Munich Leukemia Laboratory
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
STEP 2 0
University Hospital Tuebingen
PsyRareCare
Universitätsklinikum Hamburg-Eppendorf
GE-MED
University Hospital Tuebingen
Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Gradalis, Inc.
IonGER
University Hospital Tuebingen
RECAPitNETT
Hospices Civils de Lyon
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
VITA
Gradalis, Inc.
RELOAD
Istituto Ortopedico Rizzoli
Medication Adherence and Non-adherence in Adults With Rare Disease
Xperiome
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
Associazione Angela Serra per la ricerca sul cancro
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Associazione Angela Serra per la ricerca sul cancro
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
FDA Office of Orphan Products Development
Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy
FDA Office of Orphan Products Development
Randomized Study of Hormonal Regulation of Infantile Hemangioma
FDA Office of Orphan Products Development
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
FDA Office of Orphan Products Development
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
FDA Office of Orphan Products Development
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
FDA Office of Orphan Products Development
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
FDA Office of Orphan Products Development
Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
Office of Rare Diseases (ORD)
Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
National Center for Research Resources (NCRR)
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Office of Rare Diseases (ORD)
Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
National Center for Research Resources (NCRR)
Study of the Neurobiology of Tourette Syndrome and Related Disorders
National Center for Research Resources (NCRR)
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)